| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −1.1× | −1.8× | |
| Price / Book | 0.5× | 2.1× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −2.4× | −1.6× | |
| EV / EBITDA | −0.9× | −1.2× | |
| Earnings yield | −90.0% | −14.0% | |
| Free cash flow yield | −41.0% | −9.5% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,275.22 | −2.41% | $1.2T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $262.73 | −1.82% | $632.47B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.84 | +0.23% | $505.11B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $422.74 | −0.53% | $379.45B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.69 | −1.73% | $356.98B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.71 | −3.56% | $271.57B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.16 | −0.82% | $265.45B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.19 | −1.23% | $247.06B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $441.59 | −1.27% | $238.74B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $157.09 | −0.06% | $194.78B | 22.9× | 37.5% | +26.7% |
